Japanese Bridging Studies
CNS resides in the center of the largest Asian-American populated metropolitan region in the entire United States. With dedicated Japanese staff and successful Asian bridging enrollment metrics, we are in a strong position to perform these unique studies. Our database of Asian subjects includes first, second, and third generation. We have referral relationships with Asian community groups, language schools, and more.
Principal Investigator and Early Phase Medical Director Mark Leibowitz, M.D. has conducted over 20 ethno-bridging studies. Our dedicated Phase I unit has met sponsor goals for enrollment and quality on Asian bridging studies, as well as healthy subject and patient population trials.
Want to Learn More?
Whether you are a large pharmaceutical company, biopharmaceutical firm, or a maker of generic drugs, we have the expertise to expedite your decision, saving you time and money. Contact us today to learn how CNS can make your Asian Bridging research program a success.
“Both the site and the CRO have done top-notch work and we’re very pleased.”